Lademirsen

DB17611InvestigationalNucleic Acid Based Therapies

Lademirsen: Overview.

Code names
RG-012 · RG-456070 · SAR-339375

Resolves to

Compound
UNIIKKQ6AQN9LHCAS1404019-95-9

What you can answer from here — as of October 28, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Lademirsen, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In